ESR1 and breast cancer: With the ability to produce metastases from solid intraductal tumors, rather than relying on intravenous or intracardiac inoculation to produce experimental metastases, the opportunity to study the full process of metastasis and its inhibition in ER+ human breast cancer xenografts is now more widely available.